A gene therapy invented at The University of Texas M. D. Anderson Cancer Center is the first to succeed in a U.S. phase III clinical trial for cancer, as announced today at the American Society of Gene Therapy annual meeting in Boston. Introgen Therapeutics, Inc., reported results of its phase III trial of Advexin(r), a modified adenovirus ...

(From EurekAlert!). It seems as though we will have the chance to see whether widespread access to efficient therapies for cancer is good enough to ensure the healthy life extension brought about by other advances in medicine. The work presently taking place in the lab is fairly impressive: researchers ''designed a novel viral-based gene therapy ...

A growing tumor is successful in its fight to kill the aging body that hosts it by evolving its way into the set of mutations that best help its growth - but what if we could remove the best and most obvious tools from the cancer growth toolkit? Progress in that direction can be found at the Independent: ''Doctors often describe cancer as a ...

Researchers from the National Cancer Institute reported they have successfully treated two patients with advanced cancer using gene therapy. This is the first time genetically engineered immune-system cells -- specifically, T lymphocytes -- have ...